Uniferon Stungulyf, lausn 200 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

uniferon stungulyf, lausn 200 mg/ml

pharmacosmos a/s* - ferri hydroxidum dextran komplex - stungulyf, lausn - 200 mg/ml

Lumeblue (previously known as Methylthioninium chloride Cosmo) Evrópusambandið - íslenska - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - metýlþíóníumklóríð - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Monofer Innrennslislyf, lausn 100 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

monofer innrennslislyf, lausn 100 mg/ml

pharmacosmos a/s* - ferricum derisomaltosum inn - innrennslislyf, lausn - 100 mg/ml

Olysio Evrópusambandið - íslenska - EMA (European Medicines Agency)

olysio

janssen-cilag international nv - simeprevir - lifrarbólga c, langvinn - veirueyðandi lyf til almennrar notkunar - olysio er ætlað í samsettri meðferð með öðrum lyfjum til meðferðar við langvarandi lifrarbólgu c (chc) hjá fullorðnum sjúklingum. fyrir lifrarbólgu c veira (hcv) arfgerð ákveðna virkni.

Famvir Filmuhúðuð tafla 125 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

famvir filmuhúðuð tafla 125 mg

phoenix labs - famciclovirum inn - filmuhúðuð tafla - 125 mg

Cortiment Forðatafla 9 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

cortiment forðatafla 9 mg

ferring lægemidler a/s - budesonidum inn - forðatafla - 9 mg

Comirnaty Evrópusambandið - íslenska - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - bóluefni - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. notkun þetta bóluefni ætti að vera í samræmi við opinbera tillögur.

Diacomit Evrópusambandið - íslenska - EMA (European Medicines Agency)

diacomit

biocodex - stiripentol - myoclonic flogaveiki, unglinga - antiepileptics, - diacomit er ætlað til að nota með clobazami og valproati eins og venjulega meðferð svarar almenn tonic-m krampa í sjúklinga með alvarleg vöðvakippaflog flogaveiki í fæðingu (smei, dravet heilkenni) sem flog ert ekki nægilega stjórnað með clobazam og valproati.

Cozaar Comp Forte Filmuhúðuð tafla 100/25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

cozaar comp forte filmuhúðuð tafla 100/25 mg

n.v. organon* - losartanum kalíum; hydrochlorothiazidum inn - filmuhúðuð tafla - 100/25 mg

Cozaar Comp Filmuhúðuð tafla 50+12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

cozaar comp filmuhúðuð tafla 50+12,5 mg

n.v. organon* - losartanum kalíum; hydrochlorothiazidum inn - filmuhúðuð tafla - 50+12,5 mg